These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9148373)

  • 1. [Analysis of lymphocyte-T receptor in autoimmune diseases].
    Lunardi C; Borgato L; De Sandre G
    Recenti Prog Med; 1997 Feb; 88(2):82-4. PubMed ID: 9148373
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic intervention in autoimmunity.
    Tisch R; Yang XD; McDevitt HO
    Behring Inst Mitt; 1994 Jul; (94):171-8. PubMed ID: 7998910
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of autoimmune T cells among in vivo expanded CD25+ T cells in multiple sclerosis.
    Illés Z; Kondo T; Yokoyama K; Ohashi T; Tabira T; Yamamura T
    J Immunol; 1999 Feb; 162(3):1811-7. PubMed ID: 9973446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of T-cell receptor repertoire in lesions of patients with autoimmune diseases].
    Kato T; Masuko Y; Kurokawa M; Tanaka A; Hoeger T; Nishioka K; Yamamoto K
    Nihon Rinsho Meneki Gakkai Kaishi; 1995 Dec; 18(6):651. PubMed ID: 8963773
    [No Abstract]   [Full Text] [Related]  

  • 5. Immuno- and genetic therapy in autoimmune diseases.
    Chernajovsky Y; Dreja H; Daly G; Annenkov A; Gould D; Adams G; Croxford JL; Baker D; Podhajcer OL; Mageed RA
    Genes Immun; 2000 Jun; 1(5):295-307. PubMed ID: 11196690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the T cell receptor V gene usage in multiple sclerosis and human autoimmune thyroiditis.
    Ben-Nun A; Bach MA; Raus J; Davies TF
    Isr J Med Sci; 1993; 29(2-3):164-7. PubMed ID: 8468172
    [No Abstract]   [Full Text] [Related]  

  • 7. T cell receptor variable region repertoire in lymphocytes from rheumatoid arthritis patients.
    Krawinkel U; Pluschke G
    Immunobiology; 1992 Sep; 185(5):483-91. PubMed ID: 1452217
    [No Abstract]   [Full Text] [Related]  

  • 8. Focusing on the human T cell receptor for antigen.
    Grunewald J
    Sarcoidosis; 1994 Mar; 11(1):61-5. PubMed ID: 8036347
    [No Abstract]   [Full Text] [Related]  

  • 9. Humanized animal models for autoimmune diseases.
    Gregersen JW; Holmes S; Fugger L
    Tissue Antigens; 2004 May; 63(5):383-94. PubMed ID: 15104670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysfunction of T cell receptor AV24AJ18+, BV11+ double-negative regulatory natural killer T cells in autoimmune diseases.
    Kojo S; Adachi Y; Keino H; Taniguchi M; Sumida T
    Arthritis Rheum; 2001 May; 44(5):1127-38. PubMed ID: 11352245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy for autoimmune diseases.
    Furlan R; Butti E; Pluchino S; Martino G
    Curr Opin Mol Ther; 2004 Oct; 6(5):525-36. PubMed ID: 15537054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HSP70-1 promoter region polymorphism tested in three autoimmune diseases.
    Cascino I; Galeazzi M; Salvetti M; Ristori G; Morozzi G; Richiardi PM; Tosi R
    Immunogenetics; 1994; 39(4):291-3. PubMed ID: 8119737
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunotherapeutic approach to rheumatoid arthritis with anti-idiotypic antibodies to HLA-DR4.
    Quagliata F; Schenkelaars EJ; Ferrone S
    Isr J Med Sci; 1993; 29(2-3):154-9. PubMed ID: 8468170
    [No Abstract]   [Full Text] [Related]  

  • 14. Receptor-targeted immunotherapy.
    Janson RW; Arend WP
    Bull Rheum Dis; 1992; 41(3):6-8. PubMed ID: 1617334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dominant T cell receptor rearrangements in interleukin 2 expanded lymphocytes from rheumatoid nodules suggest antigen driven T cell activation in situ.
    De Keyser F; Elewaut D; Overmeer-Graus JP; Van den Broek P; Rijnders AW; Veys EM
    J Rheumatol; 1997 Sep; 24(9):1685-9. PubMed ID: 9292788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter polymorphism rs3087456 in the MHC class II transactivator gene is not associated with susceptibility for selected autoimmune diseases in German patient groups.
    Akkad DA; Jagiello P; Szyld P; Goedde R; Wieczorek S; Gross WL; Epplen JT
    Int J Immunogenet; 2006 Feb; 33(1):59-61. PubMed ID: 16426246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analyses of immunosenescent markers in patients with autoimmune disease.
    Thewissen M; Somers V; Venken K; Linsen L; van Paassen P; Geusens P; Damoiseaux J; Stinissen P
    Clin Immunol; 2007 May; 123(2):209-18. PubMed ID: 17317320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dominant and shared T cell receptor beta chain variable regions of T cells inducing synovial hyperplasia in rheumatoid arthritis.
    Mima T; Ohshima S; Sasai M; Nishioka K; Shimizu M; Murata N; Yasunami R; Matsuno H; Suemura M; Kishimoto T; Saeki Y
    Biochem Biophys Res Commun; 1999 Sep; 263(1):172-80. PubMed ID: 10486273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell receptor gene therapy for autoimmune diseases.
    Fujio K; Okamura T; Okamoto A; Yamamoto K
    Ann N Y Acad Sci; 2007 Sep; 1110():222-32. PubMed ID: 17911437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent expression of experimental autoimmune encephalomyelitis (EAE)-specific Vbeta8.2 TCR spectratype in the central nervous system of rats with chronic relapsing EAE.
    Kim G; Kohyama K; Tanuma N; Arimito H; Matsumoto Y
    J Immunol; 1998 Dec; 161(12):6993-8. PubMed ID: 9862735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.